LAVA Therapeutics Financial Overview
LAVA Therapeutics's market cap is currently $42.75M. The company's EPS TTM is $-0.267; its P/E ratio is -1.54; LAVA Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
